+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

PA

Catalog No Product Description CAS No. Purity Structural Formula
BP4397
Persicogenin
Persicogenin has anticancer, antimutagenic, and antileishmanial activities, it can inhibit the proliferation of mouse tsFT210 cancer cells, it mainly inhibits cell cycle at the G2/M phase in a dose-dependent manner. 3',5-Dihydroxy-4',7-dimethoxyflavanone is an ether and a member of flavonoids.
28590-40-1 98% Persicogenin
BP2426
Eriodictyol 7-glucuronide
Eriodictyol has vasodilator, anti-inflammatory and antioxidant activities, it is an antagonist of the transient potential vanilloid 1 receptor (TRPV1) receptor. Eriodictyol may possess antidiabetic properties through increasing glucose uptake and improving insulin resistance, it attenuates the degree of retinal inflammation and plasma lipid peroxidation preserving the blood-retinal barrier (BRB) in early diabetic rats. It may be a potential therapeutic resource for Atopic dermatitis and an adjunctive agent to control itchiness inAtopic dermatitis. (2R)-eriodictoyl-7-O-beta-D-glucopyranosiduronic acid is a beta-D-glucosiduronic acid that is the 7-O-glucuronide of (2R)-eriodictyol. Isolated from the flowers of Chrysanthemum indicum, it exhibits inhibitory activity for rat lens aldose reductase. It has a role as a metabolite and an EC 1.1.1.21 (aldehyde reductase) inhibitor. It is a beta-D-glucosiduronic acid and a 3'-hydroxyflavonoid.
618910-88-6 98% Eriodictyol 7-glucuronide
BP4571 150107-44-1 98% Fulvotomentoside A
BP3913
Saikosaponin B4
Saikosaponin B4 can selectively inhibit ACTH-induced lipolysis.
58558-09-1 98% Saikosaponin B4
BP3305
Paederosidic acid methyl ester
Paederosidic acid methyl ester has antinociception, is possibly related to the pathway of NO-cGMP-ATP sensitive K(+) channels.
122413-01-8 98% Paederosidic acid methyl ester
BP2094 76015-42-4 98% 6-Methoxytricin
BP4364 23050-38-6 98% 5,7,8-trimethoxy-2-phenyl-chromen-4-one
BP2309 2704629-41-2 98% 5-O-Sinapoylshikimic acid
BPC0078 32180-92-0 p-3-Methylamino propyl phenol
BP2007
Lonicerin
Luteolin 7-O-neohesperidoside is a disaccharide derivative that is luteolin substituted by a 2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. It has a role as a metabolite and an antibacterial agent. It is a neohesperidoside, a trihydroxyflavone, a glycosyloxyflavone and a disaccharide derivative. It is functionally related to a luteolin. Lonicerin has antioxidant, anti-arthritic and antifungal activities, it can result in a combination therapy for the treatment of fungal arthritis due to C. albicans infection.
25694-72-8 98% Lonicerin
BP2117 99365-23-8 98% Prosaikogenin G
BPC0015 3319-03-7 2-(N,N-Dimethylamino)acetophenone
BP4606
3-O-p-Coumaroylquinic acid
5-p-coumaroylquinic acid is a cinnamate ester obtained by formal condensation of the carboxy group of 4-coumaric acid with the 5-hydroxy group of ()-quinic acid. It has a role as a metabolite. It is a cinnamate ester and a cyclitol carboxylic acid. It is functionally related to a (-)-quinic acid and a 4-coumaric acid.
5746-55-4 98% 3-O-p-Coumaroylquinic acid
BP0112-1
1-Methyl-L-tryptophan
1-Methyl-L-tryptophan is an indolyl carboxylic acid.
21339-55-9 98% 1-Methyl-L-tryptophan
BP4534
5-O-Caffeoylshikimic acid
5-[(E)-caffeoyl]shikimic acid is a carboxylic ester obtained by formal condensation of the carboxy group of (E)-caffeic acid with the 5-hydroxy group of shikimic acid. It has a role as a plant metabolite. It is a cyclohexenecarboxylic acid, a carboxylic ester, a member of catechols and an alpha,beta-unsaturated monocarboxylic acid. It is functionally related to a shikimic acid and a trans-caffeic acid. It is a conjugate acid of a 5-[(E)-caffeoyl]shikimate. 5-O-Caffeoylshikimic acid shows anti-oxidative activity; it also shows anti-inflammatory activity, the underlying mechanism was associated with downregulation of nuclear factor-κB. 5-O-Caffeoylshikimic acid can remarkably inhibit the macrophage migration and adhesion. It also shows moderate MDR reversal activity.
73263-62-4 98% 5-O-Caffeoylshikimic acid
BP1319
Sodium Houttuyfonate
Sodium houttuyfonate is anti-pseudomonas agents, inhibits virulence related motility of Pseudomonas aeruginosa.It also inhibits biofilm formation and alginate biosynthesis-associated gene expression in a clinical strain of Pseudomonas aeruginosa in vitro. Sodium houttuyfonate has anti-inflammatory activity, inhibits inflammation by blocking the MAPKs/NF-κB signaling pathways in bovine endometrial epithelial cells.
83766-73-8 98% Sodium Houttuyfonate